ResearcherNational Taiwan UniversityNo recent work listed
Chih‐Hung Hsu
Matched on ORCID iD 0000-0003-0495-973X; OpenAlex author ID A5090591171. Sources: ClinicalTrials.gov.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2011: 2 papers · 2012: none · 2013: 1 paper, 1 trial · 2014: none · 2015: none · 2016: 1 paper
Papers 4
- Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer. Co-author DOI 10.3748/wjg.v22.i32.7275↗
- Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κB is associated with a poor prognosis of pancreatic cancer. First author DOI 10.1159/000353452↗
- Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced… Co-author DOI 10.1016/j.ijrobp.2010.10.034↗
- Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials. Co-author DOI 10.1159/000330817↗
Trials 1
- A Phase II Study of Locally Advanced Pancreatic Cancer Principal investigator NCT01867892↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yu‐Wen Tien · 4 shared papers, 2011–2016 · strength 0.15
- Paper Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pan… DOI 10.3748/wjg.v22.i32.7275↗
- Paper Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κB is associated with a poor prognosis of… DOI 10.1159/000353452↗
- Paper Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not partic… DOI 10.1159/000330817↗
- Ann‐Lii Cheng · 4 shared papers, 2011–2016 · strength 0.15
- Paper Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pan… DOI 10.3748/wjg.v22.i32.7275↗
- Paper Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κB is associated with a poor prognosis of… DOI 10.1159/000353452↗
- Paper Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not partic… DOI 10.1159/000330817↗
- Sung‐Hsin Kuo · 3 shared papers, 2011–2016 · strength 0.13
- Paper Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pan… DOI 10.3748/wjg.v22.i32.7275↗
- Paper Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κB is associated with a poor prognosis of… DOI 10.1159/000353452↗
- Paper Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not partic… DOI 10.1159/000330817↗
- Shih‐Hung Yang · 3 shared papers, 2011–2016 · strength 0.13
- Paper Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pan… DOI 10.3748/wjg.v22.i32.7275↗
- Paper Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κB is associated with a poor prognosis of… DOI 10.1159/000353452↗
- Paper Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not partic… DOI 10.1159/000330817↗
- Jen‐Shi Chen · 1 shared paper, 1 shared trial, 2011–2013 · strength 0.10
- Chiun Hsu · 2 shared papers, 2011–2016 · strength 0.09
- Paper Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pan… DOI 10.3748/wjg.v22.i32.7275↗
- Paper Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not partic… DOI 10.1159/000330817↗
- Yen-Shen Shen · 1 shared trial, 2013 · strength 0.08
- Ruey-Kuen Hsieh · 1 shared trial, 2013 · strength 0.08
- Hsu Wu · 1 shared paper, 2016 · strength 0.06
- Jhe‐Cyuan Guo · 1 shared paper, 2016 · strength 0.06
- Ting‐Chun Kuo · 1 shared paper, 2016 · strength 0.06
- Kun‐Huei Yeh · 1 shared paper, 2016 · strength 0.06
- Pin-Wen Lin · 1 shared paper, 2011 · strength 0.02
- Yulin Lin · 1 shared paper, 2011 · strength 0.02
- Yen‐Feng Chiu · 1 shared paper, 2011 · strength 0.02
- Li‐Tzong Chen · 1 shared paper, 2011 · strength 0.02
- Ming‐Chu Chang · 1 shared paper, 2011 · strength 0.02
- Hui-Ju Ch’ang · 1 shared paper, 2011 · strength 0.02
- Tsann‐Long Hwang · 1 shared paper, 2011 · strength 0.02
- Yan‐Shen Shan · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.